James M. Thorburn, Chief Financial Officer at Twist Bioscience Corp (TWST), sold 15,718 shares at $152.17 ($2.3M) on 2020-12-10, disclosed to the SEC on 2020-12-14.
Open-market sale of $2.3M TWST by Chief Financial Officer. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Something here stands out, but not much.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $147.87 | 5,501 | $813K | 34.7% |
| 2 | $148.69 | 6,386 | $950K | 40.5% |
| 3 | $149.62 | 1,522 | $228K | 9.7% |
| 4 | $152.17 | 2,309 | $351K | 15.0% |
| Total | $149.00 avg | 15,718 | $2.3M | 100% |
| Filing → |
| TWST | SELL | 2022-04-18 | $518K | — | Filing → |
| TWST | SELL | 2022-03-07 | $359K | — | Filing → |
| TWST | SELL | 2022-02-23 | $432K | — | Filing → |